Neuroprotective effects of the novel D 3 /D 2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole

Author: Joyce J.N.   Presgraves S.   Renish L.   Borwege S.   Osredkar T.   Hagner D.   Replogle M.   PazSoldan M.   Millan M.J.  

Publisher: Elsevier

ISSN: 0014-4886

Source: Experimental Neurology, Vol.184, Iss.1, 2003-11, pp. : 393-407

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content